Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Microbial Biotechnology|April 28, 2022
Palaeoserology - teeth put into ancient plagues and pandemicsKai DallmeierAnalytical Biochemistry|November 6, 2012
Simple and inexpensive three-step rapid amplification of cDNA 5' ends using 5' phosphorylated primersKai Dallmeier, Johan NeytsMethods in Molecular Biology (Clifton, N.J.)|December 17, 2021
Use of Optical In Vivo Imaging to Monitor and Optimize Delivery of Novel Plasmid-Launched Live-Attenuated VaccinesSapna Sharma, Kai DallmeierCell Host & Microbe|October 14, 2016
Zika and Other Emerging Viruses: Aiming at the Right TargetKai Dallmeier, Johan NeytsHuman Vaccines & Immunotherapeutics|March 2, 2025
Mission 2030: Toward universal hepatitis B immunizationElias Broeckhoven, Kai DallmeierCurrent Opinion in Virology|March 24, 2012
Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of actionJan Paeshuyse, Kai Dallmeier, Johan NeytsPlos Pathogens|December 6, 2008
Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytesKai Dallmeier, Ursula Schultz, Michael NassalReviews in Medical Virology|April 2, 2015
Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral interventionJoanna Zmurko, Johan Neyts, Kai DallmeierJournal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
Phenotyping hepatitis B virus variants: from transfection towards a small animal in vivo infection modelMichael Nassal, Kai Dallmeier, Ursula Schultz, et al.Antiviral Research|August 7, 2013
Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replicationYannick Debing, James Winton, Johan Neyts, et al.Pageof 9